177 related articles for article (PubMed ID: 34476534)
41. The development of early ascites is associated with shorter overall survival in patients with hepatocellular carcinoma treated with drug-eluting embolic chemoembolization.
Pipa-Muñiz M; Sanmartino S; Mesa A; Álvarez-Navascués C; González-Diéguez ML; Cadahía V; Rodríguez JE; Vega F; Rodríguez M; Costilla-García SM; Varela M
BMC Gastroenterol; 2020 Jun; 20(1):166. PubMed ID: 32487071
[TBL] [Abstract][Full Text] [Related]
42. Preliminary outcomes of DEB-TACE loaded with raltitrexed in the treatment of unresectable or recurrent hepatocellular carcinoma.
Bi Y; Wang Y; Zhang W; Lu H; Ren J; Han X
Cancer Imaging; 2023 Feb; 23(1):19. PubMed ID: 36814327
[TBL] [Abstract][Full Text] [Related]
43. Long Term Survival Analysis in a Cohort of 125 Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Using Small Drug Eluting Beads.
Cascella T; Garanzini EM; Lanocita R; Morosi C; Riva F; Greco G; Sposito C; Mazzaferro V; Marchianò A; Spreafico C
Cardiovasc Intervent Radiol; 2022 Jan; 45(1):54-61. PubMed ID: 34820694
[TBL] [Abstract][Full Text] [Related]
44. Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States.
Reyes DK; Vossen JA; Kamel IR; Azad NS; Wahlin TA; Torbenson MS; Choti MA; Geschwind JF
Cancer J; 2009; 15(6):526-32. PubMed ID: 20010173
[TBL] [Abstract][Full Text] [Related]
45. Comparative Study of Drug-eluting Beads versus Conventional Transarterial Chemoembolization for Treating Peculiar Anatomical Sites of Gastric Cancer Liver Metastasis.
Xu H; Min X; Ren Y; Yang L; Liu F
Med Sci Monit; 2020 May; 26():e922988. PubMed ID: 32474569
[TBL] [Abstract][Full Text] [Related]
46. Safety and Efficacy of Drug-Eluting Bead Transarterial Chemoembolization Combined with Apatinib in Patients with Advanced Hepatocellular Carcinoma.
Liu J; Xu J; Zhang W; Chen J; Zhou X; Li Z; Han X
Acad Radiol; 2020 May; 27(5):704-709. PubMed ID: 31375353
[TBL] [Abstract][Full Text] [Related]
47. [Comparison of doxorubicin-eluting bead transarterial chemoembolization (DEB-TACE) with conventional transarterial chemoembolization (TACE) for the treatment of hepatocellular carcinoma].
Ferrer Puchol MD; la Parra C; Esteban E; Vaño M; Forment M; Vera A; Cosín O
Radiologia; 2011; 53(3):246-53. PubMed ID: 21295802
[TBL] [Abstract][Full Text] [Related]
48. Exploring the efficacy and safety of drug-eluting beads transarterial chemoembolization in pancreatic cancer liver metastasis.
Ning Z; Zhu Y; Xie L; Yan X; Hua Y; Meng Z
Br J Radiol; 2024 May; 97(1157):1010-1015. PubMed ID: 38467136
[TBL] [Abstract][Full Text] [Related]
49. Efficacy of Drug-Eluting Bead Transarterial Chemoembolization in the Treatment of Colorectal Cancer Liver Metastasis.
Chen S; Yang Y; Jiao Y; Hou L; Chang H; Liu S; Yan Z
J Healthc Eng; 2022; 2022():4930047. PubMed ID: 35463654
[TBL] [Abstract][Full Text] [Related]
50. Meta-analysis: adjusted indirect comparison of drug-eluting bead transarterial chemoembolization versus
Ludwig JM; Zhang D; Xing M; Kim HS
Eur Radiol; 2017 May; 27(5):2031-2041. PubMed ID: 27562480
[TBL] [Abstract][Full Text] [Related]
51. DEB TACE for Intermediate and advanced HCC - Initial Experience in a Brazilian Cancer Center.
Luz JH; Luz PM; Martin HS; Gouveia HR; Levigard RB; Nogueira FD; Rodrigues BC; de Miranda TN; Mamede MH
Cancer Imaging; 2017 Feb; 17(1):5. PubMed ID: 28166821
[TBL] [Abstract][Full Text] [Related]
52. Increased Arterio-Portal Shunt Formation after Drug-Eluting Beads TACE for Hepatocellular Carcinoma.
Shimose S; Iwamoto H; Tanaka M; Niizeki T; Shirono T; Nakano M; Okamura S; Noda Y; Kamachi N; Sakai M; Suzuki H; Nomiyama M; Kuromatsu R; Koga H; Torimura T
Oncology; 2020; 98(8):558-565. PubMed ID: 32422633
[TBL] [Abstract][Full Text] [Related]
53. Conventional versus drug-eluting beads chemoembolization for hepatocellular carcinoma: Emphasis on the impact of tumor size.
Lee YK; Jung KS; Kim DY; Choi JY; Kim BK; Kim SU; Park JY; Ahn SH; Han KH; Kim GM; Kim MD; Park SI; Won JY; Lee DY
J Gastroenterol Hepatol; 2017 Feb; 32(2):487-496. PubMed ID: 27503585
[TBL] [Abstract][Full Text] [Related]
54. Liver-directed treatments of liver-dominant metastatic leiomyosarcoma.
Krzyston H; Morse B; Deperalta D; Rishi A; Kayaleh R; El-Haddad G; Smith J; Druta M; Kis B
Diagn Interv Radiol; 2020 Sep; 26(5):449-455. PubMed ID: 32673206
[TBL] [Abstract][Full Text] [Related]
55. Prognostic factors for survival in patients with unresectable hepatocellular carcinoma undergoing chemoembolization with doxorubicin drug-eluting beads: a preliminary study.
Dhanasekaran R; Kooby DA; Staley CA; Kauh JS; Khanna V; Kim HS
HPB (Oxford); 2010 Apr; 12(3):174-80. PubMed ID: 20590884
[TBL] [Abstract][Full Text] [Related]
56. An investigation of efficacy, safety, and prognostic factors of drug-eluting beads-transarterial chemoembolization operation with CalliSpheres
Zhang X; Lin X; Qiu H; Peng Z
J Clin Lab Anal; 2019 Oct; 33(8):e22975. PubMed ID: 31328832
[TBL] [Abstract][Full Text] [Related]
57. Efficacy and Safety of Drug Eluting Bead TACE with Microspheres <150 μm for the Treatment of Hepatocellular Carcinoma.
Sattler T; Bredt C; Surwald S; Rust C; Rieger J; Jakobs T
Anticancer Res; 2018 Feb; 38(2):1025-1032. PubMed ID: 29374736
[TBL] [Abstract][Full Text] [Related]
58. Liver, gastrointestinal, and cardiac toxicity in intermediate hepatocellular carcinoma treated with PRECISION TACE with drug-eluting beads: results from the PRECISION V randomized trial.
Vogl TJ; Lammer J; Lencioni R; Malagari K; Watkinson A; Pilleul F; Denys A; Lee C
AJR Am J Roentgenol; 2011 Oct; 197(4):W562-70. PubMed ID: 21940527
[TBL] [Abstract][Full Text] [Related]
59. The safety and efficacy of oxaliplatin-loaded drug-eluting beads transarterial chemoembolization for the treatment of unresectable or advanced lung cancer.
Bi Y; Li F; Ren J; Han X
Front Pharmacol; 2022; 13():1079707. PubMed ID: 36518678
[No Abstract] [Full Text] [Related]
60. Transarterial Chemoembolization with Doxorubicin Eluting Beads for Extra-Abdominal Desmoid Tumors: Initial Experience.
Kim D; Keohan ML; Gounder MM; Crago AM; Erinjeri JP
Cardiovasc Intervent Radiol; 2022 Aug; 45(8):1141-1151. PubMed ID: 35441242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]